Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607303 · ClinicalTrials.gov registry record
Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty
A clinical trial of Headache and Gender Identity, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 140
- Enrollment target
- 1
- Study location
NCT05607303 is a study of Headache and Gender Identity that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 140 participants, roughly in line with the 152-participant average among 35 other Headache trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05607303, a study of Headache and Gender Identity, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
With a rising population of transgender adults and youth, there is a need for more research to meet the needs of this community. Transfemale (MTF) youth (male sex, female gender identity) who begin clinical Gender Affirming Hormone Therapy (GAHT) with estrogen may be at a higher risk for headache since estrogen has been linked to headache in cisgender females (female sex, female gender identity). This research hopes to learn more about headache in MTF youth.
Conditions Studied
Interventions
- OTHER Clinical estrogen therapy
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-12-14 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05607303
The ClinicalTrials.gov registry entry for NCT05607303 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 152-participant average among 35 other Headache trials with a reported enrollment target. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 1 intervention - of which Clinical estrogen therapy is the first listed.
NCT05607303 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05607303 about?
NCT05607303 is a clinical study titled "Effect of Hormones on Frequency of Headache and Brain Structure and Function in Puberty". With a rising population of transgender adults and youth, there is a need for more research to meet the needs of this community. Transfemale (MTF) youth (male sex, female gender identity) who begin clinical Gender Affirming Hormone Therapy (GAHT) with estrogen may be at a higher risk for headache si...
What is the current status of trial NCT05607303?
This trial is currently active not recruiting. The enrollment target is 140 participants. The study started on 2021-12-14. Estimated completion is 2026-06-30.
What conditions does trial NCT05607303 study?
This clinical trial studies the following conditions: Headache, Gender Identity.
What interventions are being tested in trial NCT05607303?
The interventions under investigation include: Clinical estrogen therapy (OTHER).
Who is sponsoring clinical trial NCT05607303?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05607303 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
RECRUITING
-
Puberty, Testosterone, and Brain Development
RECRUITING
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.